Plain-English translation of NCT07116213 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a type of radiation therapy called moderately hypofractionated adaptive radiotherapy, given after surgery for endometrial (uterine) cancer. The radiation is delivered over 15 treatments using advanced technology that adjusts the beam to your body each day, followed by a few internal radiation treatments. Researchers want to see if this approach works well and causes fewer side effects than traditional radiation schedules.
Standard radiation therapy for high-risk endometrial cancer takes many weeks and can be hard on the body. This trial is exploring whether a shorter, smarter radiation schedule—using newer technology that adapts to your anatomy each day—can be just as effective while reducing side effects and improving your quality of life.
You likely qualify if…
You likely don't qualify if…
You will receive radiation therapy five days a week for about three weeks, followed by two to three internal radiation treatments spaced one to two days apart. During treatment, you'll have weekly blood tests and imaging scans to monitor your response. After treatment ends, you'll visit the clinic at three months, six months, and then every six months for up to three years, with physical exams, quality-of-life assessments, and lab work to track your recovery and long-term outcomes.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China